Skip to main content
← All trials
Healthy Volunteers, Pulmonary Arterial HypertensionHealthy volunteersDrugPhase 1, Phase 2

What this study is

A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)

What's being tested

  • LTP

    Intervention · DRUG

    LTP001

  • Placebo

    Intervention · DRUG

    Placebo

Study details

Official title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of LTP001 in Healthy Adult Participants (Part A) and to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants With Pulmonary Arterial Hypertension (Part B)
Sponsor
Novartis Pharmaceuticals
Conditions
Healthy Volunteers, Pulmonary Arterial Hypertension
Enrolling
232 people
Starts
2024-10-24
Est. completion
2028-12-31
Design
Double-blind, randomized, parallel groups, Phase 1, Phase 2
Record
View on ClinicalTrials.gov ↗